Tumor regression of an ileal carcinoid under the treatment with the somatostatin analogue SMS 201-995.
A 53-year-old man with metastatic ileal carcinoid ultimately failed to respond to conventional measures of surgery and was finally treated with a new long acting somatostatin analogue, SMS 201-995 for 7 months. SMS 201-995 not only gave symptomatic relief but also induced a reduction in metastatic tumor mass.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002276:Carcinoid Tumor / Q000000981:diagnostic imaging / Q000188:drug therapy*; D005500:Follow-Up Studies; D006801:Humans; D007078:Ileal Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy*; D008297:Male; D008303:Malignant Carcinoid Syndrome / Q000188:drug therapy; D008875:Middle Aged; D015282:Octreotide; D013004:Somatostatin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014057:Tomography, X-Ray Computed
D000970:Antineoplastic Agents; D013004:Somatostatin; D015282:Octreotide